CIK 0001788028 · <br>Emerging growth company
Jasper Therapeutics, Inc.
Sign in to watch- Ticker
- JSPR
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 842984849
- Phone
- 6505491400
- Business address
- 2200 BRIDGE PKWY SUITE #102, REDWOOD CITY, CA, 94065
- Former names
- Amplitude Healthcare Acquisition Corp
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 8-K/A Event Shareholder rights changed · Bylaws or fiscal year change · Code of ethics change
- 8-K Event Material agreement · Acquisition or sale completed · Unregistered share sale · Auditor change · Change in control · Executive or director change · Shell status change · Regulation FD disclosure
- 4 Insider Changes in Ownership
- 4 Insider Changes in Ownership
- 4 Insider Changes in Ownership
- 4 Insider Changes in Ownership
- 25-NSE Other Notification of Removal from Listing
- 8-K Event Shareholder vote results · Other events
- 425 Deal Prospectus/Communication re Business Combination
- 8-K Event Other events
- SC 13G Stake Amended Statement of Ownership
- 425 Deal Prospectus/Communication re Business Combination
- 8-K Event Regulation FD disclosure · Other events
- 425 Deal Prospectus/Communication re Business Combination
- SEC STAFF LETTER Other SEC Staff Letter Redacted Exhibit
- EFFECT Other Notice of Effectiveness
Page 19 of 25 · 484 filings